Pivotal Bio Venture Partners Investment Advisor LLC Aligos Therapeutics, Inc. Transaction History

Pivotal Bio Venture Partners Investment Advisor LLC

  • $127 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$1.04 - $2.14 $138,666 - $285,332
-133,333 Reduced 15.21%
743,215 $899,000
Q4 2020

Feb 09, 2021
BUY
$13.2 - $32.74 $11.6 Million - $28.7 Million
876,548 New
876,548 $24.2 Million

Others Institutions Holding ALGS

# of Institutions
3
Shares Held
253K
Call Options Held
0
Put Options Held
0
View Full List

About Aligos Therapeutics, Inc.

ALGS Quotes by TradingView
  • Ticker ALGS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,717,000
  • Market Cap $751M
  • Description
  • Aligos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses to develop novel therapeutics to address unmet medical needs in viral and liver diseases. Its lead drug candidate is ALG-010133, a s-antigen transport-inhibiting oligonucleotide polymer that is in Phase Ib clinical trial for the treatment of chronic hepatitis B (CHB);...
More about ALGS
Track This Portfolio

Track Pivotal Bio Venture Partners Investment Advisor LLC Portfolio

Follow Pivotal Bio Venture Partners Investment Advisor LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pivotal Bio Venture Partners Investment Advisor LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pivotal Bio Venture Partners Investment Advisor LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email